IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, today announced the full U.S. market release of the Stork smart home baby monitoring ...

Medical device maker Masimo Corp. is expanding its Irvine headquarters and plans to add about 200 workers this year. Last month, the maker of patient monitoring devices and supplies said it moved into ...

Masimo, the health technology company that made headlines last winter over a dispute with Apple and its blood oxygen sensing technology, said Monday that its wearable Stork baby monitor is now cleared ...

On March 22, 2024, Masimo MASI Corporation (NASDAQ NDAQ: MASI, $144.91, Market Capitalisation: $7.7 billion), a global leader in non-invasive monitoring technologies and audio products, announced that ...

Philips and Masimo are renewing their yearslong collaboration in patient monitoring with what they describe as an expanded focus on developing next-generation vital sign readers, plus a plan to work ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that Radius VSM™, a patient-worn, continuous multi-parameter vital signs monitor, has received FDA 510(k) clearance. Designed on ...

Masimo Corporation (NASDAQ:MASI) is one of the best NASDAQ stocks to buy in 2026. On December 5, Wells Fargo raised the ...

Masimo Corporation MASI recently announced the full U.S. market release of the Stork smart home baby monitoring system. The Stork Vitals+, Vitals, and Camera combinations are now available for ...

Universal Surveillance Monitoring with Masimo SET ® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost ...

Masimo Corporation MASI recently announced the receipt of the FDA’s clearance for Stork for prescription use with healthy and sick infants aged 0-18 months of age. Stork, Masimo’s innovative baby ...